Patrick de Geeter

963 total citations
24 papers, 630 citations indexed

About

Patrick de Geeter is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Patrick de Geeter has authored 24 papers receiving a total of 630 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Surgery, 12 papers in Pulmonary and Respiratory Medicine and 7 papers in Oncology. Recurrent topics in Patrick de Geeter's work include Bladder and Urothelial Cancer Treatments (9 papers), Prostate Cancer Diagnosis and Treatment (6 papers) and Testicular diseases and treatments (5 papers). Patrick de Geeter is often cited by papers focused on Bladder and Urothelial Cancer Treatments (9 papers), Prostate Cancer Diagnosis and Treatment (6 papers) and Testicular diseases and treatments (5 papers). Patrick de Geeter collaborates with scholars based in Germany, Austria and Belgium. Patrick de Geeter's co-authors include Michael Stöckle, Peter Albers, Hansjörg Melchior, Hendrik Van Poppel, H. Heidler, Arno Ebner, J. Hannappel, H. Madersbacher, R.L. Vereecken and Joachim W. Thüroff and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Urology and International Journal of Cancer.

In The Last Decade

Patrick de Geeter

22 papers receiving 589 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Patrick de Geeter Germany 9 359 339 227 115 112 24 630
Mounsif Azizi United States 18 488 1.4× 264 0.8× 220 1.0× 231 2.0× 92 0.8× 47 714
Priscilla Léon France 15 461 1.3× 351 1.0× 204 0.9× 334 2.9× 47 0.4× 44 857
Emanuela Trenti Italy 13 371 1.0× 190 0.6× 54 0.2× 115 1.0× 42 0.4× 45 486
Dong Deuk Kwon South Korea 14 241 0.7× 162 0.5× 103 0.5× 240 2.1× 96 0.9× 63 607
Kazuhito Matsushita United States 14 437 1.2× 268 0.8× 223 1.0× 480 4.2× 22 0.2× 29 826
Shuichi Morizane Japan 15 278 0.8× 136 0.4× 126 0.6× 322 2.8× 25 0.2× 93 619
F. Desgrandchamps France 12 146 0.4× 157 0.5× 66 0.3× 287 2.5× 86 0.8× 73 523
Jin Seon Cho South Korea 12 97 0.3× 180 0.5× 159 0.7× 370 3.2× 48 0.4× 67 507
Nachiketh Soodana‐Prakash United States 14 248 0.7× 143 0.4× 120 0.5× 369 3.2× 18 0.2× 55 601
Osamu Matsuura Japan 12 337 0.9× 119 0.4× 43 0.2× 201 1.7× 26 0.2× 85 549

Countries citing papers authored by Patrick de Geeter

Since Specialization
Citations

This map shows the geographic impact of Patrick de Geeter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick de Geeter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick de Geeter more than expected).

Fields of papers citing papers by Patrick de Geeter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick de Geeter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick de Geeter. The network helps show where Patrick de Geeter may publish in the future.

Co-authorship network of co-authors of Patrick de Geeter

This figure shows the co-authorship network connecting the top 25 collaborators of Patrick de Geeter. A scholar is included among the top collaborators of Patrick de Geeter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick de Geeter. Patrick de Geeter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Staehler, Michael, Andrej Panic, Peter J. Goebell, et al.. (2020). First‐line pazopanib in intermediate‐ and poor‐risk patients with metastatic renal cell carcinoma: Final results of the FLIPPER trial. International Journal of Cancer. 148(4). 950–960. 4 indexed citations
3.
Gschwend, Jürgen E., Matthias Heck, Jan Lehmann, et al.. (2018). Extended Versus Limited Lymph Node Dissection in Bladder Cancer Patients Undergoing Radical Cystectomy: Survival Results from a Prospective, Randomized Trial. European Urology. 75(4). 604–611. 188 indexed citations
4.
Heers, Hendrik, Patrick de Geeter, Peter J. Goebell, et al.. (2017). Vinflunine in the Τreatment of Upper Tract Urothelial Carcinoma – Subgroup Analysis of an Observational Study. Anticancer Research. 37(11). 6437–6442. 4 indexed citations
5.
Gschwend, Juergen E., Matthias Heck, Jan Lehmann, et al.. (2016). Limited versus extended pelvic lymphadenectomy in patients with bladder cancer undergoing radical cystectomy: Survival results from a prospective, randomized trial (LEA AUO AB 25/02).. Journal of Clinical Oncology. 34(15_suppl). 4503–4503. 20 indexed citations
6.
Hegele, Axel, et al.. (2015). Response to vinflunine treatment after prior platinum-based chemotherapy in patients with advanced urothelial carcinoma independent of primary tumor location.. Journal of Clinical Oncology. 33(15_suppl). e15536–e15536. 1 indexed citations
8.
Wit, Maike de, Patrick de Geeter, Luca Galli, et al.. (2015). 2640 Vinflunine maintenance treatment following first-line therapy of advanced urothelial carcinoma - results from the JASiMA trial. European Journal of Cancer. 51. S527–S527. 5 indexed citations
9.
Barski, Dimitri, Michael Richter, Craig Winter, et al.. (2012). Holmium laser ablation of the prostate (HoLAP): intermediate-term results of 144 patients. World Journal of Urology. 31(5). 1253–1259. 8 indexed citations
10.
Winter, Christian, et al.. (2012). Residual tumor resections (RTR) in patients with germ cell tumors (GCT) after salvage chemotherapy.. Journal of Clinical Oncology. 30(15_suppl). 4601–4601.
11.
Witthuhn, Ralf, et al.. (2010). Residual tumor resection in patients with germ cell tumors (GCT): Use of IGCCCG risk group and tumor volume to predict additional vascular procedures.. Journal of Clinical Oncology. 28(15_suppl). 4586–4586. 1 indexed citations
12.
Richter, Michael, et al.. (2009). Holmiumlaserablation der Prostata. Der Urologe. 48(3). 291–295. 2 indexed citations
13.
Geeter, Patrick de, et al.. (2009). Samenblasenerhaltende radikale perineale Prostatektomie. Der Urologe. 48(4). 408–414. 2 indexed citations
14.
Albers, Peter, et al.. (2009). Complications of postchemotherapy residual tumor resection in patients with germ cell cancer. Journal of Clinical Oncology. 27(15_suppl). e16077–e16077. 2 indexed citations
15.
Geeter, Patrick de, et al.. (2009). Samenblasenerhaltende radikale perineale Prostatektomie. Der Urologe. 48(6). 654–654. 1 indexed citations
16.
Albers, Peter, et al.. (2007). Seminal vesicle‐sparing perineal radical prostatectomy improves early functional results in patients with low‐risk prostate cancer. British Journal of Urology. 100(5). 1050–1054. 15 indexed citations
17.
Langner, Cord, Jana Hoffmann, Patrick de Geeter, Rainer Rompel, & Josef Rüschoff. (2001). Pigmentiertes Phäochromozytom. Der Pathologe. 22(4). 276–280. 6 indexed citations
18.
Thüroff, Joachim W., Arno Ebner, Peter Faber, et al.. (1991). Randomized, Double-Blind, Multicenter Trial on Treatment of Frequency, Urgency and Incontinence Related to Detrusor Hyperactivity: Oxybutynin versus Propantheline versus Placebo. The Journal of Urology. 145(4). 813–816. 188 indexed citations
19.
Jünemann, K.‐P., et al.. (1986). [Neurotherapy of the hyperactive bladder].. PubMed. 25(5). 288–93. 4 indexed citations
20.
Poppel, Hendrik Van, et al.. (1983). Hemospermia Owing to Utricular Cyst: Embryological Summary and Surgical Review. The Journal of Urology. 129(3). 608–609. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026